Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Interactive Journal of Medical Research

Date Submitted: Aug 21, 2024
Date Accepted: Jul 11, 2025

The final, peer-reviewed published version of this preprint can be found here:

Obesity Prevention and Reduction in China Using the Social Media Platform WeChat: Scoping Review

Wang Y, Zhuang X, Sundermeir SM, Gittelsohn J

Obesity Prevention and Reduction in China Using the Social Media Platform WeChat: Scoping Review

Interact J Med Res 2025;14:e65538

DOI: 10.2196/65538

PMID: 41380084

PMCID: 12698035

Obesity prevention and reduction in China using the social media platform WeChat: A scoping review

  • Yinuo Wang; 
  • Xuxiu Zhuang; 
  • Samantha Maria Sundermeir; 
  • Joel Gittelsohn

ABSTRACT

Background:

Digital interventions for obesity have been shown to be effective in reducing and preventing obesity. The emergence of smart phones and popular applications such as WeChat represent potential modalities that might enhance the reach and sustainability of obesity interventions and reduce costs of implementation. By the end of first quarter in 2024, there were approximately 1.36 billion monthly active users of WeChat accounting for 96.5% of the whole Chinese population The potential of this widely used app for obesity interventions has been noted in multiple Chinese intervention trials, most of which have been published in Chinese language journals.

Objective:

We aim to summarize the existing evidence on obesity interventions delivered through WeChat to provide implications for intervention development in the future, and to reach an international audience.

Methods:

A scoping review of PubMed and China National Knowledge Infrastructure (CNKI) was conducted to identify research on WeChat-assisted obesity intervention.

Results:

We conducted a scoping literature review of PubMed and CNKI, which yielded 665 initial studies. Forty-three studies met eligibility criteria and underwent data extraction to provide intervention details. Most studies (86.0%) demonstrated the efficacy of obesity interventions via WeChat in short- and long-term weight loss using objective outcome measures such as body weight, body mass index, waist circumference, hip circumference, waist-to-hip ratio and body fat percentage. However, the studies lack sufficient formative research to inform intervention development. Other common study design flaws included: lack of randomization and/or blinding (97.7%), and no reporting of intervention compliance metrics (92.0%). Most interventions were limited to the “WeChat Groups”, and “Official Accounts” (i.e., public accounts that provide health education materials to followers, record daily diet and physical activity, and other functions) features for delivery.

Conclusions:

Overall, the WeChat platform could be a promising instrument in obesity interventions, but current applications do not take full advantages of the versatile features of this app (e.g., online payment, live streaming). Future research testing the effectiveness of using WeChat for obesity interventions should include a formative phase and employ a more rigorous study design, such as a randomized controlled trial, to understand the best way to format and deliver obesity interventions using this modality.


 Citation

Please cite as:

Wang Y, Zhuang X, Sundermeir SM, Gittelsohn J

Obesity Prevention and Reduction in China Using the Social Media Platform WeChat: Scoping Review

Interact J Med Res 2025;14:e65538

DOI: 10.2196/65538

PMID: 41380084

PMCID: 12698035

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.